Skip to Content

AB Relative Value R CBBRX

Medalist Rating as of | See AllianceBernstein Investment Hub
  • NAV / 1-Day Return 6.33  /  +0.48 %
  • Total Assets 1.9 Bil
  • Adj. Expense Ratio
    1.150%
  • Expense Ratio 1.150%
  • Distribution Fee Level Average
  • Share Class Type Retirement, Medium
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Limited
  • TTM Yield 0.98%
  • Turnover 77%

USD | NAV as of Feb 26, 2024 | 1-Day Return as of Feb 26, 2024, 11:11 PM GMT+0

Morningstar’s Analysis CBBRX

Will CBBRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

There are better options elsewhere.

Analyst Eric Schultz

Eric Schultz

Analyst

Summary

AB Relative Value lacks a durable edge. It earns a Morningstar Analyst Rating of Neutral across all share classes.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CBBRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 34.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AB Government Money Market A

4.40 80.6 Mil
Cash and Equivalents

Elevance Health Inc

4.33 79.3 Mil
Healthcare

JPMorgan Chase & Co

3.92 71.7 Mil
Financial Services

Wells Fargo & Co

3.88 70.9 Mil
Financial Services

Berkshire Hathaway Inc Class B

3.83 70.2 Mil
Financial Services

Qualcomm Inc

3.66 67.1 Mil
Technology

Mastercard Inc Class A

3.50 64.0 Mil
Financial Services

Regeneron Pharmaceuticals Inc

3.11 56.9 Mil
Healthcare

Walmart Inc

2.96 54.2 Mil
Consumer Defensive

Philip Morris International Inc

2.83 51.9 Mil
Consumer Defensive